This market's growth is driven by increasing cancer research, the growing use of 3D cell culture in drug discovery and toxicology testing, the high demand for organ transplants, rising investments and funding for life science research, and the utilization of 3D cell culture models in animal testing. Additionally, emerging economies and a growing focus on regenerative medicine are expected to offer significant market growth opportunities.